PRESIDENT & CEO - CO-FOUNDER

Biotechnology executive with 25+ years of leadership in neuroscience commercialization. Glenn has held senior leadership roles at Allergan, Biogen, and Merz Neurosciences, and leads Synap's corporate strategy, financing, and business development.

CHIEF SCIENTIFIC OFFICER - CO-FOUNDER

Accomplished CNS antibody discovery leader with senior scientific roles at Denali Therapeutics, Bristol Myers Squibb, and Pfizer. Pallavi leads Synap's therapeutic discovery platform and development of multispecific VHH therapeutics.

SCIENTIFIC ADVISOR

Internationally recognized pioneer of VHH antibodies and Professor Emeritus at Vrije Universiteit Brussel (VUB). Co-inventor of the Nanobody® platform and co-founder of Ablynx.

SCIENTIFIC ADVISOR

Professor of Neurology at Stanford University and internationally recognized stroke neurologist. Leader in stroke recovery research and translational neuroscience.

SCIENTIFIC ADVISOR

Professor of Neurobiology at Technische Universität Braunschweig and internationally recognized expert in neuroplasticity and mechanisms of brain repair.

President & CEO | Board Director I Co-Founder

Seasoned biotechnology executive with more than 25 years of leadership in neuroscience commercialization. Glenn leads Synap's corporate strategy, financing, partnerships, and business development, drawing on senior leadership experience at Allergan, Biogen, and Merz Neurosciences.

Chief Scientific Officer | Board Director I Co-Founder

Industry-recognized CNS antibody discovery leader with senior scientific roles at Denali Therapeutics, Bristol Myers Squibb, and Pfizer. Pallavi provides scientific leadership for Synap's multispecific VHH therapeutic platform and guides the company's R&D strategy.

Board Director

Experienced life sciences entrepreneur and executive with expertise in drug delivery technologies, medical devices, capital formation, and company building. Brent provides strategic guidance on corporate development, financing, and commercialization.

Co-Founder | Scientific Advisory Board & Board Director

Co-Founder and Board Director with foundational contributions to Synap's scientific vision and early platform development. Nicholas continues to provide strategic scientific insight and supports the company's long-term innovation strategy.

Board Advisor

Senior life sciences executive with extensive experience in commercialization, market access, and corporate strategy. Mel advises Synap on business development, investor positioning, and strategic partnerships.